Advertisement

Topics

Concerto HealthAI Enters Precision Oncology Collaboration with Pfizer

01:08 EDT 9 Apr 2019 | Bio-Medicine

BOSTON (PRWEB) April 09, 2019 Concerto HealthAI announced today that they have entered into a collaboration with Pfizer to advance work in Precision Oncology using Concerto HealthAI’s eurekaHealthTM platform, artificial intelligence (AI) models and Real World Clinical Electronic Medical Rec...

Original Article: Concerto HealthAI Enters Precision Oncology Collaboration with Pfizer

NEXT ARTICLE

More From BioPortfolio on "Concerto HealthAI Enters Precision Oncology Collaboration with Pfizer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Pfizer
Pfizer is a global pharmaceutical company, the largest in world based on annual sales.  In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have colleagues in 180 countries. Lipitor, one of its produ...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...